Morgan Stanley Annexon, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Annexon, Inc. stock. As of the latest transaction made, Morgan Stanley holds 832,540 shares of ANNX stock, worth $2.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

832,540

Previous 701,356 18.7%

Holding current value

$2.62 Million

Previous $1.35 Million 47.67%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$1.38 - $2.73 $181,033 - $358,132	131,184 Added 18.7%	832,540 $2 Million
Q1 2025 May 15, 2025	BUY	$1.93 - $5.5 $109,390 - $311,734	56,679 Added 8.79%	701,356 $1.35 Million
Q4 2024 Feb 14, 2025	SELL	$4.44 - $7.63 $2.62 Million - $4.51 Million	-590,808 Reduced 47.82%	644,677 $3.31 Million
Q3 2024 May 14, 2025	BUY	$4.49 - $7.2 $1.02 Million - $1.63 Million	227,071 Added 22.52%	1,235,485 $7.31 Million
Q3 2024 Nov 14, 2024	BUY	$4.49 - $7.2 $1.02 Million - $1.63 Million	227,071 Added 22.52%	1,235,485 $7.31 Million
Q2 2024 May 14, 2025	BUY	$4.33 - $6.79 $1.57 Million - $2.47 Million	363,737 Added 56.42%	1,008,414 $4.94 Million
Q2 2024 Oct 17, 2024	BUY	$4.33 - $6.79 $471,541 - $739,437	108,901 Added 12.11%	1,008,414 $4.94 Million
Q2 2024 Aug 14, 2024	BUY	$4.33 - $6.79 $471,541 - $739,437	108,901 Added 12.11%	1,008,414 $4.94 Million
Q1 2024 Oct 17, 2024	SELL	$4.03 - $7.81 $438,871 - $850,516	-108,901 Reduced 10.8%	899,513 $6.45 Million
Q1 2024 Aug 16, 2024	BUY	$4.03 - $7.81 $2.85 Million - $5.53 Million	707,453 Added 368.35%	899,513 $6.45 Million
Q1 2024 May 15, 2024	BUY	$4.03 - $7.81 $2.85 Million - $5.53 Million	707,453 Added 368.35%	899,513 $6.45 Million
Q4 2023 Aug 16, 2024	SELL	$1.63 - $4.63 $1.33 Million - $3.78 Million	-816,354 Reduced 80.95%	192,060 $871,000
Q4 2023 Feb 13, 2024	BUY	$1.63 - $4.63 $70,037 - $198,941	42,968 Added 28.82%	192,060 $871,000
Q3 2023 Nov 15, 2023	BUY	$2.13 - $3.84 $88,938 - $160,339	41,755 Added 38.9%	149,092 $351,000
Q2 2023 Aug 14, 2023	SELL	$2.1 - $6.37 $64,610 - $195,985	-30,767 Reduced 22.28%	107,337 $377,000
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $198,717 - $396,372	53,133 Added 62.53%	138,104 $531,000
Q4 2022 Feb 14, 2023	BUY	$4.56 - $6.61 $136,918 - $198,471	30,026 Added 54.65%	84,971 $439,000
Q3 2022 Nov 14, 2022	SELL	$3.75 - $6.63 $214,537 - $379,302	-57,210 Reduced 51.01%	54,945 $340,000
Q2 2022 Oct 27, 2022	SELL	$2.11 - $4.06 $329,512 - $634,038	-156,167 Reduced 58.2%	112,155 $422,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $4.06 $329,512 - $634,038	-156,167 Reduced 58.2%	112,155 $422,000
Q1 2022 Oct 27, 2022	BUY	$2.73 - $11.94 $426,335 - $1.86 Million	156,167 Added 139.24%	268,322 $732,000
Q1 2022 May 13, 2022	SELL	$2.73 - $11.94 $87,291 - $381,781	-31,975 Reduced 10.65%	268,322 $732,000
Q4 2021 Feb 14, 2022	BUY	$11.49 - $22.0 $2.85 Million - $5.45 Million	247,677 Added 470.69%	300,297 $3.45 Million
Q3 2021 Nov 15, 2021	BUY	$16.35 - $23.4 $860,337 - $1.23 Million	52,620 New	52,620 $979,000

Others Institutions Holding ANNX

# of Institutions

140

Shares Held

96.5M

Call Options Held

Put Options Held

63.4K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $150M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account